(Q40572101)

21 September 2017

title

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus (English)

1 reference

neuropsychiatric systemic lupus erythematosus

21 September 2017

main subject

0 references

author name string

Neuwelt CM

1

1 reference

21 September 2017

Lacks S

2

1 reference

21 September 2017

Kaye BR

3

1 reference

21 September 2017

Ellman JB

4

1 reference

21 September 2017

Borenstein DG

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

American Journal of Medicine

21 September 2017

published in

1 reference

21 September 2017

volume

98

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

32-41

1 reference

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Central nervous system disease in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

The neurological manifestations of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Nervous system involvement in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Plasmapheresis for lupus nephritis. Lupus Plasmapheresis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

7 January 2021

Plasmapheresis in lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

inferred from DOI database lookup

7 January 2021

based on heuristic

The natural history of systemic lupus erythematosus by prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)80078-3

1 reference

release_gfovs6sq6fcqlofvztql6g5haq

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gfovs6sq6fcqlofvztql6g5haq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference